2022 American Transplant Congress » Kidney: Polyoma

7:00pm-8:00pm

BK Polyomavirus Infection is Not Associated with a Meaningful Increase in Donor-Derived Cell-Free DNA

J. Fisher¹, K. Vieira¹, R. Burke², R. Gohh¹, R. Rogers¹

7:00pm-8:00pm

BK Viremia in Living vs Deceased Donor Renal Transplant Recipients Receiving Alemtuzumab Induction

J. P. Casale¹, D. Pluckrose¹, A. Haririan², T. Sparkes¹

7:00pm-8:00pm

Dd-cfdna Correlates With Acute Rejection In The Setting Of Bk Viremia After Kidney Transplantation

N. M. Ali¹, J. Miles², V. Tatapudi¹, R. Chand¹, R. Montgomery¹

7:00pm-8:00pm

Impact of Cytomegalovirus and BK Virus Infection on Clinical Outcomes in Kidney Transplant Recipients

W. Park, J. Yang, J. Kwon, J. Lim, Y. Kim, J. Paek, K. Jin, S. Han

7:00pm-8:00pm

Infections in Kidney Transplant Recipients on Belatacept versus Tacrolimus-Based Immunosuppression

S. Gattis¹, A. Basu²

7:00pm-8:00pm

Intensive Antimetabolite Reduction is Not Associated with Increased Risk of Biopsy-Proven Acute Rejection in Kidney Transplant Recipients with BK Virus Infection; a Single Center Experience

J. Marvin¹, D. Malhotra², P. Jethwani², K. Belfield¹, E. Cohen¹

7:00pm-8:00pm

Leflunomide in Children with BK Polyomavirus Viremia After Kidney Transplant

J. Hewlett¹, K. Le Palma¹, L. Galea¹, J. Savant¹, S. Lopez¹, J. V. Rosano², A. Strong¹, B. Viteri¹, C. LaRosa¹, S. Amaral¹, B. Laskin¹

7:00pm-8:00pm

Post Transplant Virologic Outcomes in DCD Kidney Transplant Recipients Treated with Thymoglobulin Induction Immunosuppression and Maintenance Belatacept vs Calcineurin Inhibitor Therapy

T. Engebretsen¹, M. Kueht¹, A. Lea², M. Mujtaba³

7:00pm-8:00pm

Treatment of BK Virus with Weekly Intravenous Immunoglobulin in Adult Kidney Transplant Recipients

G. Girone¹, W. Asch²

7:00pm-8:00pm

Use of Everolimus and Reduced Calcineurin Inhibitors in Bk Nephropathy: Insights from Follow-Up and Surveillance Biopsies

Z. S. Zaky, M. Spinner, B. Stephany